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Abstract
Background: Natural honey (honey) is considered as a part of traditional medicine all over the world. It has both
antimicrobial and antioxidant properties, useful in stimulation of wounds and burns healing and gastric ulcers
treatment. The aim of this study, for the first time, was to investigate the antioxidant properties and protective role
of honey against carcinogen chemical aflatoxin (AF) exposure in rats, which were evaluated by histopathological
changes in liver and kidney, measuring level of serum marker enzymes [aspartate aminotransferase (AST), alanin
aminotransferase (ALT), gamma glutamil transpeptidase (GGT)], antioxidant defense systems [Reduced glutathione
(GSH), glutathione reductase (GR), superoxide dismutase (SOD), glutathione-S-transferase (GST) and catalase (CAT)],
and lipid peroxidation content in liver, erythrocyte, brain, kidney, heart and lungs.
Methods: Eighteen healthy Sprague–Dawley rats were randomly allocated into three experimental groups: A
(Control), B (AF-treated) and C (AF + honey-treated). While rats in group A were fed with a diet without AF, B, and C
groups received 25 μg of AF/rat/day, where C group additionally received 1 mL/kg of honey by gavage for 90 days.
Results: At the end of the 90-day experimental period, we found that the honey supplementation decreased the
lipid peroxidation and the levels of enzyme associated with liver damage, increased enzymatic and non-enzymatic
antioxidants in the AF + honey-treated rats. Hepatoprotective and nephroprotective effects of honey is further
substantiated by showing almost normal histological architecture in AF + honey-treated group, compared to
degenerative changes in the liver and kidney of AF-treated rats. Additionally, honey supplementation ameliorated
antioxidant defens systems and lipid peroxidation in content in other tissues of AF + honey treated rats.
Conclusion: The present study indicates that honey has a hepatoprotective and nephroprotective effect in rats
with experimental aflatoxicosis due to its antioxidant activity.
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Background
Aflatoxins (AF), a group of mycotoxins which are produced
as secondary metabolites by Aspergillus flavus and Aspergil-
lus parasiticus, are common contaminants in a wide variety
of food and feed products [1]. These toxins are produced
by fungal activity during production, harvest, transporta-
tion, storage and food processing [2]. Aflatoxin B1 (AFB1)
has teratogenic, carcinogenic, mutagenic and immunosu-
pressive effects in both humans and animals, which is the
most important and the potent hepatotoxic and hepatocar-
cinogenic agent [3] and has been classified as a carcino-
genic agent to humans by the International Agency for
Research on Cancer [4].
Oxidative stress is a common mechanism in initiation
and progression of hepatic damage in aflatoxicosis [3].
When animals or humans consume the foods containing
aflatoxins, AFB1 is metabolized in liver, producing highly
reactive chemical intermediaries which cause cell dam-
age, free radical production, and lipid peroxidation [5,
6]. Two forms of aflatoxicosis have been identified: the
first is acute severe intoxication, which results in direct
liver damage and subsequent illness or death, and the
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second is chronic subsymptomatic exposure. Symptoms
of severe aflatoxicosis include; hemorrhagic necrosis of
liver, bile duct proliferation, edema, and lethargy. In
farm and laboratory animals, chronic exposure to afla-
toxins compromises immunity and interferes with pro-
tein metabolism and multiple micronutrients those are
critical to health [7].
Natural honey (honey) is a remarkable liquid prepared
by bees from the nectar of many plants. All over the
world, it is considered as a part of traditional medicine,
especially in gastrointestinal disorders. There are few re-
ports about the effectiveness of honey in gastric ulcers
or gastrointestinal disorders in humans [8, 9]. Studies
have shown that honey has nephroprotective [10, 11],
antibacterial, anti-inflammatory and antioxidant proper-
ties [12], useful in stimulation of diabetic wounds and
burns healing [13] and gastric ulcers treatment [14]. The
carbohydrates are the main constituents, comprising
about 95 % of the honey dry weight. Beyond carbohy-
drates, honey contains numerous compounds such as
organic acids, proteins, amino acids, minerals, polyphe-
nols, vitamins and aroma compounds [15]. Additionally,
honey has rich flavonoid components [16].
Free radicals lead to oxidative damage in many mole-
cules, such as lipids, proteins and nucleic acids. Many
complications have been attributed to oxidative damage,
including atherosclerosis, aging, and cancerous diseases.
Antioxidant-rich foods that are rich in flavonoids have
protective potentials against these ailments [17].
There is no study on chemoprotective effects and anti-
oxidant roles of honey against AF-induced tissue damages
in rats. Therefore, with the present study we aimed to
examine the protective effect of honey against AF-induced
liver and kidney injury by assessing histopathology and
biochemical parameters including liver enzymes, lipid per-
oxidation and antioxidant defense systems in erythrocyte,
brain, liver, kidney, heart and lungs of rats.
Methods
Chemicals
Thiobarbituric acid (TBA), butylated hydroxytoluene
(BHT), trichloroacetic acid (TCA), ethylenediaminetet-
raacetic acid (EDTA), reduced glutathione (GSH), met-
phosphoric acid, 5,5’dithiobis-(2-nitrobenzoic acid)
(DTNB), trihydroxymethyl aminomethane (Tris), 1-
chloro-2,4-dinitrobenzene (CDNB), oxidized glutathi-
one (GSSG), β-Nicotinamide adenine dinucleotide
phosphate (reduced) (NADPH), potassium dihydrogen
phosphate (KH2PO4), hydrogen peroxide (H2O2) and
sodium chloride (NaCl) of technical grade used in this
study were supplied by Sigma Chemical Co. (St. Louis,
MO, USA). Kits for antioxidant enzymes analysis were
supplied by Randox Laboratories Ltd. The honey
sample of East Anatolia region was purchased from a
local honey store in Van, Turkey.
Aflatoxin
The AF was produced (in the Department of Pharmacol-
ogy and Toxicology, Faculty of Veterinary Medicine,
University of Selçuk, Konya; Turkey) from Aspergillus
parasitcus NRRL 2999 culture (USDA, Agricultural Re-
search Service, Peoria, IL, USA) via fermentation of rice
by the method of Shotwell et al [18] with minor modifi-
cations by Oguz [19]. Successfully fermented rice was
then steamed to kill the fungus, dried and ground to a
fine powder. The AF content in rice powder was ana-
lyzed by the method of Shotwell et al [18] and measured
on a thin layer chromatography (TLC) fluorometric
densitometer (Camag-III, Basel, Switzerland) on TLC
spots. The AF within the rice powder consisted of
72.51% AFB1, 14.05% AFB2, 9.78% AFG1 and 3.66%
AFG2 based on total AF in the ground rice powder (de-
tection limit: 1 mg AF kg–1 rice powder; recovery of the
extraction method: 92%). The rice powder was incorpo-
rated into the basal diet to provide the required amount
of feed, 25 μg of AF/rat/day.
Animals
A total of 18 Male Sprague–Dawley rats, weighing 300–
350 g, on average, at 5.5-month-old were provided by the
animal house of the Medical School of Yuzuncu Yil Univer-
sity. Animals were housed at 20 ± 2 °C in daily light/dark
cycle. All animals were kept in stainless cages and fed with
wheat-soybean-meal-based diet. Water and feed were of-
fered ad libitum. The animals received humane care ac-
cording to the criteria outlined in the ‘Guide for the Care
and Use of Laboratory Animals’ prepared by the National
Academy of Science and published by the National Insti-
tutes of Health. The ethic regulations have been followed in
accordance with The National and Institutional guidelines
for the protection of animal welfare during experiments.
Ethical approval was obtained from the Animal Experi-
ments Local Ethics Committee of Yuzuncu Yil University.
Experimental model
A total of 18 rats were randomly allocated into three ex-
perimental groups: Group A (Control, with the basal diet
without AF), group B (a diet with AF), and group C (a
diet with AF + honey), each containing 6 animals. The
rats in group B and group C received 25 μg of AF/rat/
day. The rats in group C also received 1 mL/kg of honey
by gavage for 90 days. The experiment lasted 90 days.
Animals were weighed on the 0th, 30th, 60th and 90th
days of the experiment. At the end of the 90-days ex-
perimental period, after the rats were anesthetized by in-
halation of diethyl ether, blood samples were obtained
by cardiac puncture using syringe for the determination
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of serum enzyme levels and biochemical analysis. Tissue
samples were also obtained after sacrifying the animals.
For analysis of serum enzyme levels, blood samples were
put immediately into ice-chilled siliconized disposable
glass tubes. Serum samples were obtained by centrifu-
ging blood samples at 4000 × g for 15 min. at 4 °C, and
enzyme levels were measured in the serum samples. For
biochemical analysis, blood samples were put immedi-
ately into silicon disposable glass tubes with EDTA as an
anticoagulant, which were centrifuged at 4000 × g for
15 min at 4 °C and erythrocyte pellets were obtained.
Then, pellets were washed three times with physiological
saline (0.9 % NaCl). The levels of GSH in erythrocytes
and tissues were measured immediately after the animals
were sacrificed because of tremendous loss of GSH
when delayed. The levels of GSH and MDA and the ac-
tivities of SOD, GR, CAT and GST in erythrocytes were
measured in the pellets.
Samples of the liver tissues were dissected and put in
Petri dishes. After washing the tissues with physiological
saline (0.9 % NaCl), samples were taken and kept at
-78 °C until analysis. Tissues were homogenized for
5 min in 50 mM ice-cold KH2PO4 solution (1:5 w/v)
using a glass-porcelain homogenizer (20 KHz frequency
ultrasonic, Jencons Scientific Co.) for 5 min and then
centrifuged at 7000 × g for 15 min. All processes were
carried out at 4 °C. Supernatants and homogenates were
used to determine for measurements of enzymatic and
non-enzymatic antioxidants and MDA.
Biochemical analysis
The concentrations of MDA in erythrocyte and tissues
were determined using the method described by Jain et
al [20] based on TBA reactivity. GSH concentrations in
erythrocyte and tissues were measured using the method
described by Beutler et al. [21]. CAT (EC 1.11.1.6) activ-
ity was determined using the method described by Beutler
[22]. GST (EC 2.5.1.18) was assayed at 25 oC spectro-
photometrically by following the conjugation of glutathi-
one with 1-chloro-2, 4-dinitrobenzene (CDNB) at 340 nm
as described by Mannervik and Guthenberg [23]. GR (EC
1.6.4.2) activity was assayed at 37 °C and 340 nm by fol-
lowing the oxidation of NADPH by GSSG [22]. SOD (EC
1.15.1.1) activity was measured at 505 nm and 37 °C and
calculated using inhibition percentage of formazan dye
formation [24].
Measurement of enzyme levels
Serum enzyme activities (AST (EC 2.6.1.1), ALT (E.C
2.6.1.2), and GGT (E.C. 2.3.2.2)) were measured by an
auto analyzer (BM/HITACHI-911), using kits (DPC;
Diagnostic Products Corporation, USA).
Analysis of data
All data were expressed as mean ± standard deviation (SD).
The statistical analyses were made using Minitab 13 for
windows packet program. One way ANOVA statistical test
was used to determine the differences between means of
the treatments and the control group accepting the signifi-
cance level at p ≤ 0.05. The differences among the patho-
logical changes were also determined by chi-square test.
Statements of statistical significance are based on P <0.01.
Histopathological examination
After taken from rats following scarification, liver and kid-
ney tissue samples were fixed in 10 % neutralized formalde-
hyde, embedded in paraffin wax and then stained with
hematoxylin and eosin. In addition, masson-trichrome and
sudan black B methods were used specifically to stain colla-
gen tissues and to demonstrate fatty changes, respectively.
Microscopically hepatocellular degeneration was
graded in three ways; Slight: Mild hepatocellular swell-
ing and fatty changes localized only around the periaci-
nar areas. Moderate: Clear hepatocellular swelling in
both periacinar and midzonal areas. Severe: Diffuse and
severe hepatocellular swelling, cytoplasmic pallor and
rupture [25].
Results
Effects on body weights
During the 90-days experimental period, none of the an-
imals showed any clinical signs of illness and there were
no mortality in any groups. Body weights of the rats sig-
nificantly decreased (P < 0.05) in AF-treated group, and
increased (P < 0.05) in control and AF + honey-treated
groups. Effects of AF and honey on body weights of rats
were given in Table 1
Effects on biochemical parameters
Levels of liver enzymes (AST, ALT and GGT) of control,
AF-treated and AF + honey-treated groups are summarized
in Table 2. The levels of these enzymes were significantly
elevated in AF-treated group in comparison to control
group (p < 0.05). Whereas, the levels of these enzymes were
markedly dropped in AF + honey-treated group with re-
spect to AF-treated group. Besides, there were no signifi-
cant differences in AST, ALT and GGT levels between
control and AF + honey-treated groups (Table 2).
The level of GSH and MDA, the activities of CAT,
GST, GR and SOD enzymes in tissue samples taken
from liver, lung, kidney, heart and brain of all groups are
given in Table 3. As it can be viewed in the Table, prom-
inent changes were determined. For example, there were
significant decreases in the activities of CAT, GR and
SOD in AF-treated group, when compared to control
group (p < 0.05). As compared with AF-treated group,
honey supplementation significantly ameliorated the
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activities of the antioxidant enzymes (CAT, GR and
SOD) in some tissues. Furthermore, there were no sig-
nificant differences in the levels of these antioxidant en-
zymes between control and AF + honey-treated groups
(p < 0.05).
MDA levels of tissue and erythrocytes in rats were signifi-
cantly higher in AF-treated group and AF + honey-treated
group in comparison to the control group (p <0.05). How-
ever, MDA levels of tissue and erythrocytes in AF + honey-
treated group were considerably, in most cases significantly,
lower than those of the AF-treated group (p < 0.05). This
result indicating restorative effects of honey on the MDA
levels of tissue and erythrocytes (Table 3).
Histopathological findings
No gross lesions were observed in the hepatic structure
of rats in control and AF + honey-treated groups. How-
ever, the livers of the AF-treated group were mild pale
and swollen. The gross and histopathological lesions and
the number of affected animals are summarized in
Table 4, in which the severity of the changes was classi-
fied from slight to severe.
The livers of rats from control group had normal
histological appearance (Fig. 1). Marked histopatho-
logical lesions were consistently observed in livers of all
rats from AF-treated group. Inspections of the liver sec-
tions showed severe histopathological changes in all rats
of this group. Predominantly, hydropic degeneration,
necrotic changes and dysplastic changes in hepatocytes
were detected. We noted that cloudy swelling or
vacuolar-hydropic degenerative hepatocytes had located
particularly in the periacinar and intermediate regions of
the liver lobules and characterized with large foci of he-
patocytes with granulated cytoplasm. Some hepatocytes
in the periportal regions had moderate to severe cyto-
plasmic vacuolation, indicating fatty change. This
condition was confirmed with Sudan black B stain. Par-
tially normal-looking hepatocytes were encountered in
the parenchyma resided usually in the periportal areas
and among the degenerative foci. But often focal necro-
sis were formed in this regions (Figs. 2 and 3). In these
areas, the nuclei of some cells were picnotic or karyor-
rhectic, and their cytoplasms were either lysed or eo-
sinophilic. Furthermore, the nuclei of the hepatocytes
were of different sizes and showed varying degrees of
staining; while hepatocytes possessed two nuclei, others
contained 2-4 prominent nuclei. The cytoplasm and nu-
clei of some degenerative hepatocytes were noted to be
very large and abnormally shaped (megalocytosis) (Fig. 4).
Moreover, the vesicular shaped nuclei of some degener-
ated hepatocytes showed marginal hyperchromasia and
they were empty. Additionally, mitotic figures were en-
countered in some degenerative hepatocytes. The ar-
rangement of remark cords was impaired owing to
severe degenerations and the compressive focal atrophy
was formed in the parenchyma around the severe degen-
erative cell foci. Hyperemia in some veins and sinusoids,
increase of the number perisinusoidal cells, and intrahe-
patic cholestasis (Fig. 5) were also noticed. Likewise, epi-
thelial hyperplasia in the bile ducts and an increase in
the number of bile ducts, and focal mononuclear cell in-
filtration in the portal area were observed in five of the
six rats in group B (AF-treated group) (Fig. 6). Although
an increase in connective tissue was observed in portal
gaps, there were no proliferations of the connective tis-
sue spreading to the parenchyma from portal gaps.
Alterations were also noted in the livers of the rats in
AF + honey treated group but these changes were signifi-
cantly less when compared to the rats in the AF-treated
group. Examinations of livers in this group showed slight
hydropic degenerations and necrotic changes. Lesions
were localized in some liver lobules in the form of de-
generative cell foci with fewer cells. However, the archi-
tectures of lobules were intact (Fig. 7). Moreover, some
apoptotic and dysplastic cells as well as megalocytic he-
patocytes were rarely encountered. Proliferation in the
bile ducts in two of the six rats in this group and light
periportal fibrosis in one rat were also noted.
Kidney sections of control rats showed normal histo-
logical appearance of the glomeruli, and renal tubules in
the cortical and medullary portions. Marked histopatho-
logical changes were observed in kidney of rats from
Table 1 Effects of AF and honey on body weight of rats
Parameters A (Control) B (AF-treated) C (AF + Honey-treated)
Mean ± SD Mean ± SD Mean ± SD
Body weight (g) Beginning Final Beginning Final Beginning Final
322 ± 2.9 335 ± 1.8a 325 ± 2.1 312 ± 1.9b 323 ± 1.6 334 ± 2.3a
Each value represents the Mean ± SDa: significantly different from control, b: significantly different from group B at p < 0.05 (One way ANOVA)
Table 2 Effects of AF and honey on serum enzyme levels of
rats
Parameters A (Control) B (AF-treated) C (AF + Honey-treated)
Mean ± SD Mean ± SD Mean ± SD
AST (U/L) 161.5 ± 39.2 248.5 ± 66.6a 183.3 ± 32.4b
ALT (U/L) 43.0 ± 9.1 115.5 ± 27.7a 57.2 ± 7.3b
GGT (U/L) 0.1 ± 0.04 2.8 ± 1.2a 0.84 ± 0.08ab
Each value represents the Mean ± SD. a: significantly different from control, b:
significantly different from B group rats at p < 0.05 (One way ANOVA)
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AF-treated group. These changes; degeneration and coagu-
lation necrosis of proximal tubule epithelial cells,
hyperemia in arterioles, glomerular and interstitial capillar-
ies and hyaline casts in some of the tubule lumens. Further-
more, megalocytic cells were seen in tubular epithelium
(Fig. 8).
In AF + honey-treated group, the kidney tissue ex-
hibited normal histological appearance similar to the
control group. However, slight degenerative and nec-
rotic changes were seen in some tubule epithelial cells.
There was also presence of capillary hyperemia (Fig. 9).
Histopathological lesions and the number of affected
Table 3 Effects of AF and honey on antioxidant defense system and MDA contents in various tissues of rats
Tissue Parameters A (Control) B (AF-treated) C(AF + Honey-treated)
Mean ± SD Mean ± SD Mean ± SD
Erythrocyte GSH mg/dl 39.5 ± 0.84 38,8 ± 1,2 43,8 ± 1,5
MDA nmol/ml 0,39 ± 0,08 0,69 ± 0,2a 0,49 ± 0,1ab
CAT U/ml 461.1 ± 40.4 112.6 ± 12.1a 401.4 ± 147.1b
GST U/ml 0,62 ± 0,16 0,75 ± 0,39 0,35 ± 0,21
GR U/ml 0.37 ± 0.12 0.7 ± 0.34a 0.85 ± 0.29a
SOD U/ml 428,6 ± 10,5 443,5 ± 3,5 436,5 ± 13,5
Brain GSH mg/g 28.4 ± 4.4 32.5 ± 5.4 33.7 ± 3.8
MDA nmol/g 34.1 ± 2.4 38.1 ± 3.4 38.3 ± 4.7
CAT U/g 54.9 ± 13.3 52.3 ± 21.5 55.6 ± 12.2
GST U/g 2.6 ± 0.3 2.6 ± 0,3 2.8 ± 0,5
GR U/g 0.94 ± 0.2 0.83 ± 0.14 0.73 ± 0.07
SOD U/g 1511.7 ± 115.2 1605.1 ± 55.3 1631.6 ± 55.3
Liver GSH mg/g 27,5 ± 2,1 21,8 ± 0,5a 24,6 ± 1,5
MDA nmol/g 35,4 ± 3,04 73,7 ± 13,8a 49,1 ± 8,1ab
CAT U/g 79,7.4 ± 13.2 30.8 ± 13.7a 66.3 ± 17.6b
GST U/g 8,8 ± 1,2 8,7 ± 2,7 8,5 ± 1,6
GR U/ml 1.34 ± 0.1 0.85 ± 0.11a 0.80 ± 0.19a
SOD U/g 1879,7 ± 36,8 1451,9 ± 275a 1582,5 ± 90a
Kidney GSH mg/g 46.5 ± 0.6 45.7 ± 1.9 45.7 ± 1.8
MDA nmol/g 6.3 ± 2.5 72.9 ± 43.8a 11.9 ± 3.1ab
CAT U/g 24.1 ± 11.9 24.8 ± 14.7 20.7 ± 2.8
GST U/g 6.5 ± 1.1 5.3 ± 0,3 4.6 ± 0,4
GR U/g 0.37 ± 0.1 0.26 ± 0.1 0.3 ± 0.1
SOD U/g 1504.7 ± 161.8 1485.6 ± 303.6 1468.3 ± 250.7
Heart GSH mg/g 36.4 ± 0.9 39.6 ± 2.3 41.1 ± 1.7
MDA nmol/g 7.12 ± 1.2 21.8 ± 1.2a 8.3 ± 3.1b
CAT U/g 22.8 ± 1.5 16.7 ± 4.1 16.7 ± 6.3
GST U/g 2.5 ± 0.19 2.8 ± 0,2 2.17 ± 0,3
GR U/g 1.2 ± 0.16 1.15 ± 0.06 1.15 ± 0.06
SOD U/g 1349.3 ± 69.4 1471.3 ± 78.5 1467.9 ± 8.2
Lungs GSH mg/g 39.9 ± 4.8 27.8 ± 3.5a 39.4 ± 3.2
MDA nmol/g 11.8 ± 2.8 73.4 ± 11.8a 42.3 ± 6.1ab
CAT U/g 43.5 ± 14.2 37.5 ± 17.6 37.5 ± 22.3
GST U/g 6.2 ± 1.3 5.7 ± 1,2 3.3 ± 0,5
GR U/g 1.3 ± 0.14 1.5 ± 0.08 1.2 ± 0.2
SOD U/g 1879.8 ± 36.8 1643.6 ± 112.1a 1582.6 ± 89.9a
Each value represents the Mean ± SD. a: significantly different from control, b: significantly different from B group rats at p < 0.05 (One way ANOVA)
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animals are summarized in Table 4, in which the
severity of the changes was classified from slight to
severe.
Discussion
The present study, for the first time, demonstrated that the
treatment with honey effectively protected the rat against
AF-induced hepatotoxicity, as evidenced by decreased
AST, ALT and GGT levels and hepatic lipid peroxidation
and elevated antioxidants levels. These protective effects of
honey against AF-induced hepatotoxicity were also con-
firmed by histopathological investigation.
Previous studies indicate that body weights of the rats
receiving AFB1 decreases. Body weights in mice are re-
ported to be reduced by a range from 37 to 55 % depend-
ing on dose and duration of AFB1 exposure [26].
Aflatoxicosis is shown to cause hypoproteinemia by pre-
venting protein synthesis; thereby, causing loss of body
weight [27]. Results in the present study also demon-
strated that the rats fed with AF had less body weight at
the end of the 90-days experimental period, as compared
with control group, whereas, there were increases in body
weight at the end of the 90-days experimental period in
the rats that received AF + honey and control rats.
The known histopathological and biochemical findings
of the AFB1 toxicity in rats were also observed in the
present study. The hepatotoxic effects of AF have been
well documented in a variety of animal species [28, 29].
The main mechanism by which aflatoxin induces hep-
atotoxicity is formation of reactive oxygen species (ROS)
and consequent peroxidative damage [30]. AFB1 is
shown to induce lipid peroxidation in cells via inducing
A2 and thereby disrupts the integrity of cell membranes
[31]. AFB1 can also stimulate formation of ROS [32],
occurrence of lipid peroxidation, and generation of 8-
hydroxydeoxyguanosine [33]. Considering the role of
Table 4 Effects of AF and honey on the Liver and kidney structure







1. Enlargement and palaness -/6b 2/6a -/6b *
slight * 2 *
Moderate * * *
Severe * * *
2. Hydrolic degeneration/ or fatty changes -/6b 6/6a 6/6c
Slight * * 4 **
Moderate * 2 2
Severe * 4 *
3. Dysplastic hepatocytes -/bb 6/6a 4/6c **
Slight * * 2
Moderate * 3 2
Severe * 3 *
4. Bile-duct proliferation -/6b 5/6a 2/6c **
5. Periportal fibrosis -/6b 6/6a 1/6b *
Slight * 2 1
Moderate * 2 *
Severe * 2 *
6. Degeneration and necrosis in renal tubule epithelial cells -/6b 6/6a 2/6c *
Slight * 2 2
Moderate * 4 *
Severe * * *
7. Megalocytosis in renal tubule epithelial cells -/6b 2/6a -/6b
Slight * 2 *
Moderate * * *
Severe * * *
The values present the number of rats showing change/number of rats examined in each treatment group. Values with different letters (a, b and c) in same row
are significantly different (P <0.01), according to the Chi-Square tests.
*P >0.05
**P <0.01
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ROS in chemically induced carcinogenesis, the ability of
AFB1 to induce oxidative damage to cells and DNA may,
in addition to the formation of AFB1–DNA adducts, play
an important role in AFB1 carcinogenicity [34]. Generation
of epoxide derivatives produced via aflatoxin metabolism,
which depend on especially hepatic microsomal cyto-
chrome P-450, is suggested to play a crucial role on the
emergence of AFB1 toxicity and its carcinogenic effects
[35]. Moreover, these epoxide metabolites are reported to
disturb cell integrity through binding to macromolecules
such as nucleoproteins and nucleic acids, and consequently
inhibiting enzyme and protein synthesis [35, 36]. These en-
zyme systems (hepatic microsomal cytochrome P-450) are
revealed to be localized at the highest concentration in the
hepatocytes residing in the vicinity of periacinar areas of
the liver [37]. In our study, histopathological changes such
as cloudy swelling, hydropic degeneration, and focal
necrosis were noted primarily in the periacinar regions and
intermediate regions of liver lobules of the animals in treat-
ment groups, especially AF-treated group. Primarily periaci-
nar and secondarily intermediate localizations of liver
lesions in aflatoxicosis are also emphasized by other re-
searchers [38, 39]. Moreover, hepatocellular degeneration in
aflatoxicosis is graded in three ways: 1) mild lesions charac-
terized with hepatocellular swelling due to hydropic degen-
eration and fatty changes, 2) moderate lesions distinguished
with clear hepatocellular swelling confined around the peri-
acinar and midzonal areas, and 3) severe lesions typified
with diffused-severe hepatocellular swelling, cytoplasmic
pallor and rupture [25]. In the current study, we noted dis-
tribution of similar lesions that are presented in Table 4.
Aflatoxicosis is shown to cause several microscopic
changes in the liver, i.e., development of cytomegaly, for-
mation of evident nucleolus, appearance of marginal
Fig. 1 Control (Grup A): Normal histological appearance of the liver.
H. E. Bar = 200 μ
Fig. 2 AF-treated group: Large degenerative and necrotic areas in
liver parenchyme. H. E. Bar = 200 μ
Fig. 3 AF-treated group: Degeneration and necrosis of hepatocytes.
H. E. Bar = 50 μ
Fig. 4 AF-treated group: Dysplastic hepatocytes, nucleus of which
demonstrates anenlarged, hyperchromatic and pleomorphic
appearence with a coarse chromatin pattern, their cytoplasms
distincly large (megalocytosis) H. E. Bar = 25 μ
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hyperchromasia, and occurrence of hepatocytes with two
nuclei [38]. Likewise, in the present study we noted similar
changes in hepatocytes particularly in AF-treated group
and less in honey + AF-treated group. This observation
might be probably related to increased RNA and DNA
synthesis owing to aflatoxin-associated suppression of cell
division as stated by the study of Gabliks et al. [40].
Several studies indicate that aflatoxicosis causes epithe-
lial hyperplasia and proliferation in the liver bile ducts [41,
42]. The severetiy of these changes increases as a function
of dose of AFB1 and its duration of availability. Besides,
aflatoxicosis causes necrotic changes in the liver, which is
one of the liver reactions to any damages to the liver [38].
In this study, epithelial proliferation and hyperplasia were
observed in five cases in the AF-treated group and in two
cases in AF +Honey treated group, indicating the recu-
perative effect of honey on liver bile ducts of the rats suf-
fering from aflatoxicosis.
Increase in the levels of serum AST, ALT and GGT re-
flects loss of structural integrity of the liver. These en-
zymes are released into the bloodstream in the presence
of hepatocellular degeneration and necrotic changes,
resulting in, thereby, elevation of levels of serum AST,
ALT and GGT [43]. In the current study, as shown in
Table 2, while AF caused a significant elevation in the
levels of AST, ALT and GGT in rats treated with AF, there
were no significant differences in the levels of these en-
zymes between the AF + honey treated group and control
group. Namely, administration of honey restored the in-
creased activities of enzymes induced by AF to their con-
trol levels. These findings suggest that honey may have
protective effects on the damages caused by AFB1, as evi-
denced by decreased AST, ALT and GGT levels.
Fig 5 AF-treated group: Intrahepatic cholestasis (thin arrows) and
vesicular nuclei (thick arrow). H. E. Bar = 25 μ
Fig 6 AF-treated group: Bile-duct hyperplasia (arrows) H. E. Bar = 50 μ
Fig 7 AF + honey treated group: Slightly degenerative and dysplastic
hepatocytes in parenchyme and foci of degenerative cells (arrows).
H. E. Bar = 100 μ
Fig 8 AF-treated group: Necrosis in renal proximal tubular
epithelium (thin arrows) and megalosit tubule epithelial cells (thick
arrow) with capillary hyperemia. H. E. Bar = 25 μ
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Several studies indicate that AFB1 causes degenerative
and necrotic changes in proximal tubular epithelial cells
[44, 45] and hyaline casts [38] in the tubule lumen. Fur-
thermore, enlargement of epithelial nuclei was demon-
strated in an experimental aflatoxicosis study [26]. In the
presented study, similar findings were observed in the
AF-treated group. However, with the supplementation of
honey these histological changes were significantly de-
creased in AF + honey-treated group. These histological
results confirmed by biochemical findings. As a result,
honey feeding protects the kidney against AF nephrotox-
icity through reducing tubular damage, including tubular
degeneration and necrosis, and MDA levels.
Membrane lipids are very sensitive to harmful effects
of reactive oxygen species [46, 47]. The removal of one
hydrogen atom is the initiating step in lipid peroxidation
from an unsaturated fatty acid chains under the effect of
ROS, which, in turn, result in an increase of MDA level
[48, 49]. MDA is a widely used as an index of lipid per-
oxidation [50] and increased MDA content is an import-
ant indicator of oxidative membrane damage [51]. In the
present study, MDA concentrations significantly in-
creased in the erythrocyte, liver and kidney of rats
treated with AF, which seem to be resulted from in-
creased levels of ROS as a result of stress condition in
the rats with AF intoxication. But honey treatment re-
versed the increased MDA contents to the control level,
which is suggestive of that honey may be successful in
quenching the free radicals, inhibiting lipid peroxidation
and protecting membrane lipids from oxidative damage
in liver of rats. The honey is shown to possess phyto-
chemicals like flavonoids, effective in scavenging free
radicals [52]. This might explain the reduction in MDA
levels that we observed in the present study when honey
was added to diet of the rats.
The increased activities of SOD, GR and CAT are
known to serve as protective enzymes for elimination of
reactive free radicals [53]. SOD catalyzes the dismutation
of superoxide into oxygen and H2O2, and CAT is re-
sponsible for inactivating H2O2 into water and oxygen
[54]. The finding in the present study showed that anti-
oxidant enzyme activities such as SOD and CAT de-
creased significantly in the liver of the AF-exposed
group, whereas the activities of these enzymes of AF +
honey group were comparable with those of control
group. The observation that application of honey caused
the levels of SOD and CAT to increase to their normal
levels in the AF + honey-treated rats indicates that the
liver is restored to its normal activity by the protective
action of honey. Honey possesses phytochemicals like
flavanoids, which have been shown to be effective in
scavenging free radicals [50]. This fact is further sub-
stantiated by the decrease in the levels of MDA upon
honey administration. The ancillary enzyme GR activ-
ities in the erythrocytes of AF and AF + honey were
higher than those in control group. Meanwhile, there
were no significant differences in the activity of the drug
metabolizing enzyme GST in tissues between the treat-
ment groups. The reasons for such effects of honey are
not understood at the present.
Conclusions
It is concluded that honey with antioxidant properties
appears to have a protective role in AF toxicity as it en-
hances the activities of liver function, decreasing level of
MDA and the serum AST, ALT and GGT. The honey
supplementation reduce the formation of the ROS or
scavenges of these groups. Therefore, honey could has a
potential rol as antioxidant for food supplementation or
pharmaceutical industry. Further experiments should be
performed to understand the underlying mechanism re-
sponsible for changing the balance between the oxidative
processes and antioxidant defense systems, and serum
marker enzymes.
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